Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2200-2205

  Lamendola, Diana E ^a   Duan, Zhenfeng ^a   Yusuf, Rushdia Z ^a   Seiden, Michael V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PACLITAXEL; RNA;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; CALCULATION; CANCER CELL CULTURE; CELL GROWTH; CELL STRUCTURE; COMPUTER PROGRAM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DRUG EXPOSURE; EVALUATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MAPPING; GENE PROBE; GENE SEGREGATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PRIORITY JOURNAL; SIGNAL PROCESSING; SIGNAL TRANSDUCTION;

ALGORITHMS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0038713475     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Kurella, M., Hsiao, L. L., Yoshida, T., Randall, J. D., Chow, G., Sarang, S. S., Jensen, R. V., and Gullans, S. R. DNA microarray analysis of complex biologic processes. J. Am. Soc. Nephrol., 12: 1072-1078, 2001.
2. Kohonen, T. Self-organizing maps. Berlin: Springer, 1995.
3. Toronen, P., Kolehmainen, M., Wong, G., and Castren, E. Analysis of gene expression data using self-organizing maps. FEBS Lett., 451: 142-146, 1999.
4. Sherlock, G. Analysis of large-scale gene expression data. Curr. Opin. Immunol., 12: 201-205, 2000.
5. Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E. S., and Golub, T. R. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. USA, 96: 2907-2912, 1999.
6. Dieckgraefe, B. K., Stenson, W. F., Korzenik, J. R., Swanson, P. E., and Harrington, C. A. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol. Genomics, 4: 1-11, 2000.
7. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Lander, E. S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash. DC), 286: 531-537, 1999.
8. Nielsen, T. O., West, R. B., Linn, S. C., Alter, O., Knowling, M. A., O'Connell, J. X., Zhu, S., Fero, M., Sherlock, G., Pollack, J. R., Brown, P. O., Botstein, D., and van de Rijn, M. Molecular characterization of soft tissue tumours: a gene expression study. Lancet, 359: 1301-1307, 2002.
9. Staunton, J. E., Slonim, D. K., Coller, H. A., Tamayo, P., Angelo, M. J., Park, J., Scherf, U., Lee, J. K., Reinhold, W. O., Weinstein, J. N., Mesirov, J. P., Lander, E. S., and Golub, T. R. Chemosensitivity prediction by transcriptional profiling. Proc. Natl. Acad. Sci. USA, 98: 10787-10792, 2001.
10. van't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-536, 2002.
11. Dan, S., Tsunoda, T., Kitahara, O., Yanagawa, R., Zembutsu, H., Katagiri, T., Yamazaki, K., Nakamura, Y., and Yamori, T. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res., 62: 1139-1147, 2002.
12. Butte, A. J. Tamayo, P., Slonim, D., Golub, T. R., and Kohane, I. S. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc. Natl. Acad. Sci. USA, 97: 12182-12186, 2000.
13. Chauhan, D., Auclair, D., Robinson, E. K., Hideshima, T., Li, G., Podar, K., Gupta, D., Richardson, P., Schlossman, R. L., Krett, N., Chen, L. B., Munshi, N. C., and Anderson, K. C. Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays. Oncogene, 21: 1346-1358, 2002.
14. Hilsenbeck, S. G., Friedrichs, W. E., Schiff, R., O'Connell, P., Hansen, R. K., Osborne, C. K., and Fuqua, S. A. Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. J. Natl. Cancer Inst. (Bethesda), 91: 453-459, 1999.
15. Watts, G. S., Futscher, B. W., Isett, R., Gleason-Guzman, M., Kunkel, M. W., and Salmon, S. E. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J. Pharmacol. Exp. Ther., 299: 434-441, 2001.
16. Li, C., and Wong, W. H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA, 98: 31-36, 2001.
17. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25: 25-29, 2000.
18. Germann, U. A. P-Glycoprotein: a mediator of multidrug resistance in tumour cells. Eur. J. Cancer, 32A: 927-944, 1996.
19. Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J., et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA, 91: 8822-8826, 1994.
20. Tang, C., Willingham, M. C., Reed, J. C., Miyashita, T., Ray, S., Ponnathpur, V., Huang, Y., Mahoney, M. E., Bullock, G., and Bhalla, K. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia (Baltimore), 8: 1960-1969, 1994.
21. Strobel, T., Kraeft, S. K., Chen, L. B., and Cannistra, S. A. BAX expression is associated with enhanced intracellular accumulation of paclitaxel: a novel role for BAX during chemotherapy-induced cell death. Cancer Res., 58: 4776-4781, 1998.
22. Dumontet, C., and Sikic, B. I. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J. Clin. Oncol., 17: 1061-1070, 1999.
23. Li, X., Marani, M., Mannucci, R., Kinsey, B., Andriani, F., Nicoletti, I., Denner, L., and Marcelli, M. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res., 61: 1699-1706, 2001.
24. Noutomi, T., Chiba, H., Itoh, M., Toyota, H., and Mizuguchi, J. Bcl-x(L) confers multi-drug resistance in several squamous cell carcinoma cell lines. Oral Oncol., 38: 41-48, 2002.
25. Radetzki, S., Kohne, C. H., von Haefen, C., Gillissen, B., Sturm, I., Dorken, B., and Daniel, P. T. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene, 21: 227-238, 2002.
26. Duan, Z., Feller, A., Toh, H., Makatsoris, T., and Seiden, M. V. TRAG-3 a novel gene isolated from a taxol resistant ovarian carcinoma. Gene (Amst.), 229: 75-81, 1999.
27. Duan, Z., Feller, A., Penson, R. T., Chabner, B., and Seiden, M. V. Discovery of differentially expressed genes associated with Taxol resistance using cDNA array technology: analysis of IL-6, IL-8 and MCP-1 in the Taxol-resistant phenotype. Clin. Cancer Res., 5: 3445-3453, 1999.
28. Duan, Z., Duan, Y., Lamendola, D. E., Yusuf, R. Z., Nacem, R., Penson, R. T., and Seiden, M. V. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin resistant human cancer cell lines. Clin. Cancer Res., in press, 2003.
29. Duan, Z., Lamendola, D. E., Brakora, K., Yusuf, R. Z., and Seiden, M. V. cDNA array technology identifies MGC 4175 and GBP-2 as paclitaxel resistance associated genes (TRAGs). Proc. Am. Assoc. Cancer Res., in press, 2003.
30. Cowen, L. E., Nantel, A., Whiteway, M. S., Thomas, D. Y., Tessier, D. C., Kohn, L. M., and Anderson, J. B. Population genomics of drug resistance in Candida albicans. Proc. Natl. Acad. Sci. USA, 99: 9284-9289, 2002.
31. Matsushima, K., Baldwin, E. T., and Mukaida, N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem. Immunol., 51: 236-265, 1992.
32. Power, C. A., Church, D. J., Meyer, A., Alouani, S., Proudfoot, A. E., Clark-Lewis, I., Sozzani, S., Mantovani, A., and Wells, T. N. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3α from lung dendritic cells. J. Exp. Med., 186: 825-835, 1997.
33. Prossnitz, E. R., and Ye, R. D. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther., 74: 73-102, 1997.
34. Ledent, C., Vaugeois, J. M., Schiffmann, S. N., Pedrazzini, T., El Yacoubi, M., Vanderhaeghen, J. J., Costentin, J., Heath, J. K., Vassart, G., and Parmentier, M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (Lond.), 388: 674-678, 1997.
35. Mantovani, A. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Investig., 71: 5-16, 1994.
36. Penson, R. T., Kronish, K., Duan, Z., Feller, A. J., Stark, P., Cook, S. E., Duska, L. R., Fuller, A. F., Goodman, A. K., Nikrui, N., MacNeill, K. M., Matulonis, U. A., Preffer, F. I., and Seiden, M. V. Cytokines IL-1β, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF-α in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int. J. Gynecol. Cancer, 10: 33-41, 2000.
37. Lee, L. F., Schuerer-Maly, C. C., Lofquist, A. K., van Haaften-Day, C., Ting, J. P., White, C. M., Martin, B. K., and Haskill, J. S. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res., 56: 1303-1308, 1996.
38. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Wash. DC), 258: 1798-1801, 1992.
39. Wang, J. M., Taraboletti, G., Matsushima, K., Van Damme, J., and Mantovani, A. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem. Biophys. Res. Commun., 169: 165-170, 1990.
40. Duan, Z., Lamendola, D. E., Penson, R. T., Kronish, K. M., and Seiden, M. V. Overexpression of IL-6 but not IL-8 increases Paclitaxel resistance of U-2OS human osteosarcoma cells. Cytokine, 17: 234-242, 2002.
41. Kleeff, J., Kusama, T., Rossi, D. L., Ishiwata, T., Maruyama, H., Friess, H., Buchler, M. W., Zlotnik, A., and Korc, M. Detection and localization of Mip-3α/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int. J. Cancer, 81: 650-657, 1999.
42. Sugita, S., Kohno, T., Yamamoto, K., Imaizumi, Y., Nakajima, H., Ishimaru, T., and Matsuyama, T. Induction of macrophage-inflammatory protein-3α gene expression by TNF-dependent NF-κB activation. J. Immunol., 168: 5621-5628, 2002.
43. Mercurio, F., and Manning, A. M. NF-κB as a primary regulator of the stress response. Oncogene, 18: 6163-6171, 1999.
44. Cassatella, M. A., Bazzoni, F., Ceska, M., Ferro, I., Baggiolini, M., and Berton, G. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formylmethionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J. Immunol., 148: 3216-3220, 1992.
45. Link, A. A., Kino, T., Worth, J. A., McGuire, J. L., Crane, M. L., Chrousos, G. P., Wilder, R. L., and Elenkov, I. J. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J. Immunol., 164: 436-442, 2000.
46. Bivalacqua, T. J., Champion, H. C., Lambert, D. G., and Kadowitz, P. J. Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed. Am. J. Physiol. Regul. Integr. Comp. Physiol., 282: R1696-R1709, 2002.
47. Diaz, J. F., and Andreu, J. M. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry, 32: 2747-2755, 1993.
48. Linse, K., and Mandelkow, E. M. The GTP-binding peptide of β-tubulin. Localization by direct photoaffinity labeling and comparison with nucleotide-binding proteins. J. Biol. Chem., 263: 15205-15210, 1988.
49. Shivanna, B. D., Mejillano, M. R., Williams, T. D., and Himes, R. H. Exchangeable GTP binding site of β-tubulin. Identification of cysteine 12 as the major site of cross-linking by direct photoaffinity labeling. J. Biol. Chem., 268: 127-132, 1993.
50. 1-S transition in mammalian cells. Mol. Cell. Biol., 19: 5083-5095, 1999.
51. Gilks, C. B., Bear, S. E., Grimes, H. L., and Tsichlis, P. N. Progression of interleukin-2 (IL-2)-dependent rat T-cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol. Cell. Biol., 13: 1759-1768, 1993.
52. Latres, E., Chiarle, R., Schulman, B. A., Pavletich, N. P., Pellicer, A., Inghirami, G., and Pagano, M. Role of the F-box protein Skp2 in lymphomagenesis. Proc. Natl. Acad. Sci. USA, 98: 2515-2520, 2001.
53. Zhang, H., Kobayashi, R., Galaktionov, K., and Beach, D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S-phase kinase. Cell, 82: 915-925, 1995.
54. Hashino, E., Shero, M., Junghans, D., Rohrer, H., Milbrandt, J., and Johnson, E. M., Jr. GDNF and neurturin are target-decived factors essential for cranial parasympathetic neuron development. Development (Camb.), 128: 3773-3782, 2001.
55. Baldassarre, G., Bruni, P., Boccia, A., Salvatore, G., Melillo, R. M., Motti, M. L., Napolitano, M., Belletti, B., Fusco, A., Santoro, M., and Viglietto, G. Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). Oncogene, 21: 1739-1749, 2002.
56. Carlomagno, F., Vitagliano, D., Guida, T., Napolitano, M., Vecchio, G., Fusco, A., Gazit, A., Levitzki, A., and Santoro, M. The kinase inhibitor PPI blocks tumorigenesis induced by RET oncogenes. Cancer Res., 62: 1077-1082, 2002.
57. Santoro, M., Melillo, R. M., Carlomagno, F., Fusco, A., and Vecchio, G. Molecular mechanisms of RET activation in human cancer. Ann. N. Y. Acad. Sci., 963: 116-121, 2002.
58. Chen, B. C., Wu, W. T., Ho, F. M., and Lin, W. W. Inhibition of interleukin-1β-induced NF-κB activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88. J. Biol. Chem., 277: 24169-24179, 2002.
59. Cao, Z., Henzel, W. J., and Gao, X. IRAK: a kinase associated with the interleukin-1 receptor. Science (Wash. DC), 271: 1128-1131, 1996.
60. Ray, K., Kunsch, C., Bonner, L. M., and Robishaw, J. D. Isolation of cDNA clones encoding eight different human G protein [IMAGE] subunits. Including three novel forms designated the [IMAGE](4), [IMAGE][IMAGE], and [IMAGE][IMAGE] subunits. J. Biol. Chem., 270: 21765-21771, 1995.
61. Seiden, M. V., Swenerton, K. D., Matulonis, U., Rose, P., Baptist, G., Ette, E., Garg, V., Fuller, A., Harding, M. W., and Charpentier, D. A Phase II study of the MDR inhibitor biricodar (incel™, vx-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy. Gynecol. Oncol., 86: 302-307, 2002.
62. Sawiris, G. P., Sherman-Baust, C. A., Becker, K. G., Cheadle, C., Teichberg, D., and Morin, P. J. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res., 62: 2923-2928, 2002.